DrugPatentWatch Database Preview
Litigation Details for Galderma Laboratories LP v. Taro Pharmaceuticals USA Inc (N.D. Tex. 2016)
» See Plans and Pricing
Galderma Laboratories LP v. Taro Pharmaceuticals USA Inc (N.D. Tex. 2016)
| Docket | Start Trial | Date Filed | 2016-07-29 |
| Court | District Court, N.D. Texas | Date Terminated | 2017-05-24 |
| Cause | 35:271 Patent Infringement | Assigned To | James E. Kinkeade |
| Jury Demand | Plaintiff | Referred To | |
| Parties | TARO PHARMACEUTICAL INDUSTRIES LTD | ||
| Patents | 8,445,543; 8,785,420; 8,809,305 | ||
| Attorneys | Clyde Moody Siebman | ||
| Firms | DLA Piper | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Galderma Laboratories LP v. Taro Pharmaceuticals USA Inc
The small molecule drugs covered by the patents cited in this case are Start Trial and Start Trial .
Details for Galderma Laboratories LP v. Taro Pharmaceuticals USA Inc (N.D. Tex. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-11-27 | 32 | infringement of U.S. Patent Nos. 8,445,543 (the “’543 Patent”), 8,785,420 (the “’420 Patent”), and 8,809,305…8,809,305 (the “’305 Patent”), collectively “the patents-in-suit.” Generally, the patents-in-suit relate to…asserted patents, which are purportedly owned by Galderma R&D. Without an exclusive patent license… patents-in-suit, and any foreign counterparts or priority applications to the patents-in- … patents-in-suit; • Plaintiffs’ theories regarding alleged infringement of the patents-in-suit | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
